Study on the Ownership for Human Research Specimens

碩士 === 銘傳大學 === 法律學系碩士在職專班 === 106 === Since the 20th century, medical biotechnology has shown a high degree of progress and development. In addition to the unremitting efforts of government supporters and researchers around the world, it is also grateful to the participants who provide their own re...

Full description

Bibliographic Details
Main Authors: HSU, REN-JUN, 許仁駿
Other Authors: HUANG,YU-HUI
Format: Others
Language:zh-TW
Published: 2018
Online Access:http://ndltd.ncl.edu.tw/handle/7648gs
id ndltd-TW-106MCU01194013
record_format oai_dc
spelling ndltd-TW-106MCU011940132019-07-25T04:46:40Z http://ndltd.ncl.edu.tw/handle/7648gs Study on the Ownership for Human Research Specimens 人體研究材料權利歸屬之研究 HSU, REN-JUN 許仁駿 碩士 銘傳大學 法律學系碩士在職專班 106 Since the 20th century, medical biotechnology has shown a high degree of progress and development. In addition to the unremitting efforts of government supporters and researchers around the world, it is also grateful to the participants who provide their own research specimens and engage researchers in scientific research. However, the academic, government, and even legal circles do not have exhaustive protection responsibilities for the rights and interests of these participants. This study focuses on the discussion of multiple judgments on the rights of human research specimens in US courts, and discusses the protection of human rights in human research materials, including civil law, human research methods, human biological management regulations, and artificial reproduction laws. In order to explore the rights and obligations of research specimens in research institutions or researchers, and research specimens providers, and the discussion on the collection and use of behaviors and regulations in biomedical research institutions. The results of the study are as follows: (1) The tissue isolated from the human body is used as a research specimens and its ownership belongs to the provider. (2) The medical residual specimens are converted to the appropriateness of the research specimens. The medical institutions should return to the human body research method, and only after signing the consent form, the remaining specimens can be converted into research specimens. (3) The legitimacy of the re-use of the remaining biomedical research materials after the completion of the study shall not be decided by the Institutional Review Board, which is supervised by a third party. (4) For the no purpose of providing no future research, human research methods should not be used to collect medical/study remaining research specimens. HUANG,YU-HUI 黃鈺慧 2018 學位論文 ; thesis 136 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 銘傳大學 === 法律學系碩士在職專班 === 106 === Since the 20th century, medical biotechnology has shown a high degree of progress and development. In addition to the unremitting efforts of government supporters and researchers around the world, it is also grateful to the participants who provide their own research specimens and engage researchers in scientific research. However, the academic, government, and even legal circles do not have exhaustive protection responsibilities for the rights and interests of these participants. This study focuses on the discussion of multiple judgments on the rights of human research specimens in US courts, and discusses the protection of human rights in human research materials, including civil law, human research methods, human biological management regulations, and artificial reproduction laws. In order to explore the rights and obligations of research specimens in research institutions or researchers, and research specimens providers, and the discussion on the collection and use of behaviors and regulations in biomedical research institutions. The results of the study are as follows: (1) The tissue isolated from the human body is used as a research specimens and its ownership belongs to the provider. (2) The medical residual specimens are converted to the appropriateness of the research specimens. The medical institutions should return to the human body research method, and only after signing the consent form, the remaining specimens can be converted into research specimens. (3) The legitimacy of the re-use of the remaining biomedical research materials after the completion of the study shall not be decided by the Institutional Review Board, which is supervised by a third party. (4) For the no purpose of providing no future research, human research methods should not be used to collect medical/study remaining research specimens.
author2 HUANG,YU-HUI
author_facet HUANG,YU-HUI
HSU, REN-JUN
許仁駿
author HSU, REN-JUN
許仁駿
spellingShingle HSU, REN-JUN
許仁駿
Study on the Ownership for Human Research Specimens
author_sort HSU, REN-JUN
title Study on the Ownership for Human Research Specimens
title_short Study on the Ownership for Human Research Specimens
title_full Study on the Ownership for Human Research Specimens
title_fullStr Study on the Ownership for Human Research Specimens
title_full_unstemmed Study on the Ownership for Human Research Specimens
title_sort study on the ownership for human research specimens
publishDate 2018
url http://ndltd.ncl.edu.tw/handle/7648gs
work_keys_str_mv AT hsurenjun studyontheownershipforhumanresearchspecimens
AT xǔrénjùn studyontheownershipforhumanresearchspecimens
AT hsurenjun réntǐyánjiūcáiliàoquánlìguīshǔzhīyánjiū
AT xǔrénjùn réntǐyánjiūcáiliàoquánlìguīshǔzhīyánjiū
_version_ 1719229809427480576